Evidence map›Paper›PMID 41454963›Full record

ArticleAntonie van Leeuwenhoek2025

Codon usage bias of low-risk human papillomavirus types 6 and 11.

Jiani Yang, Liangeng Liu, Shunyou Jing, Weifeng Shen, Xiaochun Tan

Abstract read
PubMed Publisher
In one paragraph

Article in Antonie van Leeuwenhoek, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiani Yang *Department of Laboratory Medicine, Yancheng TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, China.
Liangeng Liu *Department of Laboratory Medicine, Yancheng TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, China.
Shunyou Jing *Department of Clinical Laboratory, Sichuan Provincial Women's and Children's Hospital/The Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, China.
Weifeng ShenDepartment of Laboratory Medicine, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, 1882 South Central Road, Jiaxing, China.
Xiaochun TanDepartment of Laboratory Medicine, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, 1882 South Central Road, Jiaxing, China. 110chunchunchun@163.com.

Funding

Jiaxing Key Discipline of Medicine-Clinical Diagnostics 2023-ZC-002Medical Research Project Fund of Yancheng Health Commission YK2024126the "Venus" Talent Training Program of the Jiaxing First Hospital 2022-QXM-019Zhejiang Provincial Medical and Health Technology Program 2025KY354
6 · The paper itself

Abstract

Low-risk human papillomaviruses HPV-6 and HPV-11 impose a substantial global burden of benign disease. While genomically similar to high-risk HPV types, their codon usage patterns remain uncharacterized. This study systematically deciphers these patterns in HPV-6 and HPV-11. Analysis included 214 HPV-6 and 100 HPV-11 genomes from the NCBI GenBank database. Genomic analysis identified a strong preference for A/U-ending synonymous codons (over 85% of preferred codons) and low GC content at third codon positions (<35%). Relative dinucleotide abundance analysis further revealed underrepresentation of ApA, CpG, and UpC, and overrepresentation of CpA and UpG, which critically shaped synonymous codon selection in both genotypes. While Effective Number of Codons (ENC) values >49 indicated limited overall codon bias, multi-method analyses (Parity Rule 2, ENC-plot, neutrality plot) established natural selection as the dominant evolutionary force over mutational pressure. Despite moderate host adaptation, a strategic mismatch exists between viral codon preferences and human tRNA abundance, potentially moderating translational efficiency to favor immune evasion and persistence. The Relative Codon Deoptimization Index (RCDI) values approaching 2 further support a moderate adaptation to human codon usage patterns. These findings provide crucial insights into the molecular evolution of low-risk HPVs and inform the development of codon-optimized therapeutic strategies, including vaccines targeting pathologies like genital warts and recurrent respiratory papillomatosis.

Indexed as

CodonCodon UsageHuman papillomavirus 11Human papillomavirus 6Base CompositionEvolution, MolecularGenome, ViralGenotypeHuman Papillomavirus VirusesHumansPapillomavirus InfectionsSelection, GeneticCodonCodon usage biasHost adaptationHPV-11HPV-6Natural selection

Identifiers

PMID41454963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.